Dale Solomon, MD
Internal Medicine · Kingsport, TNNPI 1134185242
Payments from drug & device makers
Across 77 payments — averaging $15.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$142
- Pfizer$117
- Sanofi-aventis U.S. LLC$111
- GSK$98
- E.r. Squibb & Sons, L.L.C.$96
- Inogen, Inc.$89
- plus $567 from 14 others
What the payments were for
- Food & beverage$1,219100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 8 | $142 |
| Pfizer | 8 | $117 |
| Sanofi-aventis U.S. LLC | 7 | $111 |
| GSK | 6 | $98 |
| E.r. Squibb & Sons, L.L.C. | 6 | $96 |
| Inogen, Inc. | 8 | $89 |
| Esperion Therapeutics, Inc. | 4 | $89 |
| Amarin Pharma, Inc. | 4 | $75 |
| Amgen | 5 | $70 |
| Lilly USA, LLC | 4 | $66 |
| Boehringer Ingelheim | 3 | $52 |
| AstraZeneca | 3 | $41 |
| Johnson & Johnson | 3 | $36 |
| Circassia Inc. | 2 | $29 |
| Eisai Inc. | 1 | $24 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $22 |
| Exact Sciences | 1 | $20 |
| AbbVie | 1 | $16 |
| Novartis | 1 | $14 |
| Dexcom, Inc. | 1 | $13 |
How this compares
$1,219 in reported general payments places this provider in the 70th percentile of 2,216 internal medicine providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 223 | $190,653 |
| JardianceEmpagliflozin | 81 | $80,462 |
| FarxigaDapagliflozin Propanediol | 91 | $65,762 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 53 | $36,532 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 13 | $29,380 |
| XareltoRivaroxaban | 39 | $28,678 |
| MounjaroTirzepatide | 25 | $26,570 |
| OzempicSemaglutide | 16 | $20,769 |
| LinzessLinaclotide | 25 | $17,873 |
| Tresiba Flextouch U-100Insulin Degludec | 15 | $16,624 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 21 | $13,607 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 12 | $9,811 |
| BrilintaTicagrelor | 14 | $9,257 |
| MyrbetriqMirabegron | 15 | $8,991 |
| Breo ElliptaFluticasone/Vilanterol | 18 | $7,325 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $117 | $190,653223 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Brilinta, Symbicort | $41 | $114,751172 claims |
| Boehringer IngelheimJardiance | $52 | $80,46281 claims |
| Johnson & JohnsonXarelto | $36 | $28,67839 claims |
| Lilly USA, LLCMounjaro | $66 | $26,57025 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $98 | $20,93239 claims |
| Novo NordiskOzempic | $142 | $20,76916 claims |
| AbbVieLinzess, Synthroid | $16 | $19,67063 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 2,216 internal medicine providers in Tennessee.
Other internal medicine in Kingsport
- Jewel WhiteKingsport$5.7M
- Judith WhiteKingsport$5.6M
- David MorinKingsport$1.4M
- Mark McKenzieChattanooga$11.9M
- Bernard GrunstraBristol$6.4M
- Obadias MarquezOoltewah$2.8M
- Amanda Moore MillerKnoxville$2.3M
- Rick WhilesBristol$1.5M
- John AndersonNashville$1.5M
- John KirbyJefferson City$1.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.